Compare ASGI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASGI | PHAR |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 798.5M | 793.4M |
| IPO Year | 2019 | 2020 |
| Metric | ASGI | PHAR |
|---|---|---|
| Price | $18.92 | $11.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $35.70 |
| AVG Volume (30 Days) | ★ 221.9K | 14.4K |
| Earning Date | 01-01-0001 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.98 |
| Revenue Next Year | N/A | $8.95 |
| P/E Ratio | ★ N/A | $3,041.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.90 | $9.11 |
| 52 Week High | $25.95 | $21.34 |
| Indicator | ASGI | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | 47.19 |
| Support Level | $18.92 | $9.37 |
| Resistance Level | $19.69 | $13.50 |
| Average True Range (ATR) | 0.47 | 0.46 |
| MACD | -0.13 | -0.17 |
| Stochastic Oscillator | 3.65 | 9.59 |
abrdn Global Infrastructure Income Fund is a non-diversified, closed-end management investment company. Its objective is to seek to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.